Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
850.6 DKK
-2.58%
Market Closed
Updated:
May 6, 2024
Novo Nordisk A/S
Total Other Income
|
Novo Nordisk A/S
Total Other Income Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Total Other Income
-kr197m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Total Other Income
-kr53m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Total Other Income
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Total Other Income?
Total Other Income
-197m
DKK
-197m
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Total Other Income amounts to -197m DKK.
What is Novo Nordisk A/S's Total Other Income growth rate?
Total Other Income CAGR 5Y
-22%
-22%
Over the last year, the Total Other Income growth was -9%. The average annual Total Other Income growth rates for Novo Nordisk A/S have been -10% over the past three years , -22% over the past five years .
You don't have any saved screeners yet
